Regulation 2 Amendments to the National Health Service (Pharmaceutical Services) (Wales) Regulations 2020I1
England and Wales
The National Health Service (Pharmaceutical Services) (Wales) Regulations 2020f1 are amended as follows.
In regulation 2(1) (Interpretation)—
in the definition of “Electronic prescription form”, in paragraph (b), for “ETP” substitute “electronic prescription”,
omit the definition of “ETP service”,
in the appropriate place, insert—
““Prescription only medicine” (“meddyginiaeth a roddir ar bresgripsiwn yn unig”) means a medicine referred to in regulation 5(3) (classification of medicinal products) of the Human Medicines Regulations 2012;”, and
in the definition of “Repeatable prescription”, in paragraph (a)(ii), for “ETP” substitute “electronic prescription”.
In Schedule 5—
in Part 2, in the heading to paragraph 5Af2 before “listed”, in each place it occurs, insert “ophthalmic”,
in Part 2, in paragraph 5A—
for “a listed”, in each place it occurs, substitute “an ophthalmic listed”;
in sub paragraph (3)(a), for “paragraph” substitute “sub-paragraph”; and
in sub-paragraph (5), for “paragraph” substitute “sub-paragraph”;
in Part 2, in paragraph 9f3, in sub-paragraph (8C)(b), omit “directly”;
in Part 2, for paragraph 20(4)f4 substitute—
“(4)The NHS pharmacist must, in appropriate cases, keep and maintain a record of any advice given and any interventions or referrals made (in particular of clinically significant interventions) under this paragraph.”;
in Part 3, in paragraph 23(6B)f5, for “paragraph” substitute “sub-paragraph”.
Annotations
Commencement
- I1
Reg. 2 in force at 1.4.2025 at 12.01 a.m., see reg. 1(3)
Footnotes
- f1
-
S.I. 2020/1073 (W. 241), amended by S.I. 2024/1196 (W. 196); there are other amending instruments, but none are relevant.
- f2
-
Paragraph 5A inserted by S.I. 2024/1196 (W. 196).
- f3
-
Paragraph 9(8C)(b) inserted by S.I. 2024/1196 (W.196).
- f4
-
Paragraph 20(4) substituted by S.I. 2024/1196 (W. 196).
- f5
-
Paragraph 23(6B) inserted by S.I. 2024/1196 (W. 196).